Global Radiopharmaceuticals In Nuclear Medicine Market Growth Over The Forecast 2018 to 2026

Technological advancements in imaging have brought many changes such as the introduction of hybrid technology — positron emission tomography/computed tomography (PET/CT) and single-photon emission computed tomography/computed tomography (SPECT/CT). Combination of the anatomic details provided, for instance, by CT, with the important and much needed functional, physiologic or metabolic information provided by molecular imaging has been facilitated with the use of hybrid imaging.

More accurate diagnosis is possible with the help of hybrid imaging with increased specificity, attenuation correction, and localization. Moreover, usage of PET/CT has been established in clinical practice and has added significant value in the areas of neurology, cardiology, and oncology. Moreover, SPECT/CT has also been established and has been used in areas such as cardiology, liver/spleen imaging, thyroid imaging, cancer diagnosis, and others.

Hybrid imaging (PET/CT) along with radiopharmaceuticals such as 18F-fluorodeoxyglucose (18F-FDG), the most frequently used molecule in the PET diagnosis, 18F-fluorothymidine (18F-FLT), 18F-fluorocholine (18F-FCH), 18F-fluoro-ethyltyrosine (18F-FET), 18F-fluorodihydroxyphenylalanine (18F-FDOPA), 11C-methionine (11C-MET) or 18F-fluoromisonidazole (18F-FMISO), 68Ga-DOTA derivatives, 68Ga-PSMA, 18F-florbetaben or 18F-flutemetamol for brain amyloid beta imaging has been widely used (according to European Journal of Radiology, 2017). These factors drive growth of the market and further developments in PET cameras and other technologies is expected to boost growth of the market over the forecast period.

Some major players operating in the global radiopharmaceuticals in nuclear medicine market include Progenics Pharmaceuticals, Inc., NorthStar Medical Radioisotopes LLC, Curium Pharma, Life Molecular Imaging, Lantheus Holdings, Inc., Cardinal Health, Inc., General Electric Company, Bracco S.p.A., Bayer AG, Advanced Accelerator Applications, S.A., and Eli Lilly and Company.

Request Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/70

To comprehend 2018-2026 Radiopharmaceuticals Market dynamics in the world mainly, the worldwide 2018-2026 Radiopharmaceuticals Market is analyzed across major global regions. CMI also provides customized specific regional and country-level reports for the following areas.

• North America: United States, Canada, and Mexico. • South & Central America: Argentina, Chile, and Brazil. • Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa. • Europe: UK, France, Italy, Germany, Spain, and Russia. • Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia.

** One country of specific interest can be included at no added cost. For inclusion of more regional segment quote may vary.

2-Page profiles for 10+ leading manufacturers and 10+ leading retailers is included, along with 3 years financial history to illustrate the recent performance of the market. Revised and updated discussion for 2018 of key macro and micro market influences impacting the sector are provided with a thought-provoking qualitative comment on future opportunities and threats. This report combines the best of both statistically relevant quantitative data from the industry, coupled with relevant and insightful qualitative comment and analysis.

In order to get a deeper view of Market Size, competitive landscape is provided i.e. Revenue (Million USD) by Players (2013-2018), Revenue Market Share (%) by Players (2013-2018) and further a qualitative analysis is made towards market concentration rate, product/service differences, new entrants and the technological trends in future.

Receive Sample on Radiopharmaceuticals Research: https://www.coherentmarketinsights.com/insight/request-sample/70

Competitive Analysis:

The research report on Radiopharmaceuticals Market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2018-2026. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities. The report classifies the market into different segments based on technique, application and end-user. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.

Purchase Copy of This Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/70

1001 4th Ave,, #3200, Seattle, WA 98154

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.